S Ima Nirwana
Overview
Explore the profile of S Ima Nirwana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ima Nirwana S, Fakhrurazi H
Med J Malaysia
. 2013 Dec;
57(2):136-44.
PMID: 24326643
The aim of this study was to determine the effects of palm oil-derived vitamin E on glucocorticoid-induced osteoporosis. Three-month old male Wistar rats were adrenalectomised to remove circulating glucocorticoids. The...
2.
Fairus A, Ima Nirwana S, Elvy Suhana M, Tan M, Santhana R, Farihah H
Clin Ter
. 2013 Mar;
164(1):5-10.
PMID: 23455734
Objectives: Visceral obesity may be due to the dysregulation of cortisol production or metabolism that lead to metabolic disease. In adipose tissue, the enzyme 11beta-hydroxysteroid dehydrogenase type 1 regulates cortisol...
3.
Nazrun Jr A, Chew C, Norazlina M, Kamsiah J, Ima Nirwana S
Malays J Nutr
. 2012 Jun;
13(1):89-99.
PMID: 22692192
The use of repeatedly heated frying oils and intake of high cholesterol diet have been linked to bone damage. The aim of this study is to determine the combined effects...
4.
Nadia M, Nazrun A, Norazlina M, Isa N, Norliza M, Ima Nirwana S
Adv Pharmacol Sci
. 2012 May;
2012:706905.
PMID: 22611381
Osteoporosis is characterized by skeletal degeneration with low bone mass and destruction of microarchitecture of bone tissue which is attributed to various factors including inflammation. Women are more likely to...
5.
Nizar A, Nazrun A, Norazlina M, Norliza M, Ima Nirwana S
Clin Ter
. 2012 Jan;
162(6):533-8.
PMID: 22262323
Aims: Vitamin E is an antioxidant that may protect bone against oxidative stress-induced osteoporosis. This in vitro study was conducted to determine the protective effects of a-tocopherol and γ-tocotrienol on...
6.
Nazrun A, Norazlina M, Norliza M, Ima Nirwana S
Adv Pharmacol Sci
. 2011 Dec;
2012:142702.
PMID: 22162676
There is growing evidence that inflammation may be one of the causal factors of osteoporosis. Several cytokines such as IL-1, IL-6, RANKL, OPG, and M-CSF were implicated in the pathogenesis...
7.
Elvy Suhana M, Farihah H, Faizah O, Nazrun S, Norazlina M, Norliza M, et al.
Clin Ter
. 2011 Sep;
162(4):313-8.
PMID: 21912818
Aims: Osteoporosis is a proven complication of long-term glucocorticoid therapy. Concern on glucocorticoid induced osteoporosis has increased dramatically in recent years with the widespread use of synthetic glucocorticoids. Glucocorticoid action...
8.
Ahmad N, Khalid B, Luke D, Ima Nirwana S
Clin Exp Pharmacol Physiol
. 2005 Sep;
32(9):761-70.
PMID: 16173934
1. Free radicals generated by ferric nitrilotriacetate (FeNTA) can activate osteoclastic activity and this is associated with elevation of the bone resorbing cytokines interleukin (IL)-1 and IL-6. In the present...